Search results
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Motley Fool via Yahoo Finance· 3 days agoAmgen is an established big pharma company with a massive pipeline and many avenues for growth...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoTruqap™ (capivasertib) plus fulvestrant now available in Canada Canada NewsWire MISSISSAUGA, ON, May 31, 2024 MISSISSAUGA, ON, May 31, 2024 /CNW/ - AstraZeneca is pleased ...
Germany’s ITM raises $205M as radiopharma field booms
BioPharma Dive via Yahoo Finance· 13 hours agoBristol Myers spent $4.1 billion to buy RayzeBio; AstraZeneca paid $2 billion for Fusion...
Cramer's Lighting Round: ‘You've got a winner' with Astra Zeneca
NBC Los Angeles· 6 days ago“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to...
ACT Foundation congratulates Quebec Minister of Education on announcement to expand AEDs to all...
Digital Journal· 5 hours agoThe ACT High School CPR and AED Program is made possible with the support of its national health partners, AstraZeneca Canada and Amgen Canada, and provincial and community ...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 4 days agoInterim safety and efficacy results of the Phase Ib/II Destiny-BREAST07 trial with Enhertu...
G42, an Emirati AI hopeful, has big plans
The Economist· 8 hours agoTHE MIDDLE EAST is something of a tech desert. One company trying to change this is G42, founded six years ago in the United Arab Emirates (UAE). More...
Health Care Roundup: Market Talk
The Wall Street Journal· 7 days agoKeytruda is the world’s top-selling drug and raked in about $25 billion in revenue for Merck last year. (ben.glickman@wsj.com; @benglickman) 1151 ET – ...
Astra’s Enhertu delays breast cancer in patients with low HER2 levels
WSAU Wausau· 4 days agoBy Deena Beasley (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to...
Move over 'Magnificent 7,' the 'Fantastic 5' may offer higher earnings and return potential
CNBC· 10 hours agoLooking for a less risky way to find growth stocks amid all the artificial intelligence hype?...